Advanced search
1 file | 797.61 KB

Stimulating pharmaceutical innovation in the EU

Author
Organization
Keywords
clinical trials, medical needs, intellectual property rights, orphan medicines, pharmaceutical innovation

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 797.61 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Annemans, Lieven, Irina Cleemput, Frank Hulstaert, and Steven Simoens. 2011. “Stimulating Pharmaceutical Innovation in the EU.” Expert Review of Pharmacoeconomics & Outcomes Research.
APA
Annemans, Lieven, Cleemput, I., Hulstaert, F., & Simoens, S. (2011). Stimulating pharmaceutical innovation in the EU. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH.
Vancouver
1.
Annemans L, Cleemput I, Hulstaert F, Simoens S. Stimulating pharmaceutical innovation in the EU. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. 2011. p. 235–9.
MLA
Annemans, Lieven, Irina Cleemput, Frank Hulstaert, et al. “Stimulating Pharmaceutical Innovation in the EU.” EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH 2011 : 235–239. Print.
@misc{2014491,
  author       = {Annemans, Lieven and Cleemput, Irina and Hulstaert, Frank and Simoens, Steven},
  issn         = {1473-7167},
  keyword      = {clinical trials,medical needs,intellectual property rights,orphan medicines,pharmaceutical innovation},
  language     = {eng},
  number       = {3},
  pages        = {235--239},
  series       = {EXPERT REVIEW OF PHARMACOECONOMICS \& OUTCOMES RESEARCH},
  title        = {Stimulating pharmaceutical innovation in the EU},
  url          = {http://dx.doi.org/10.1586/ERP.11.19},
  volume       = {11},
  year         = {2011},
}

Altmetric
View in Altmetric
Web of Science
Times cited: